Loading...

Home
Stock
TECH

TECH News & Events

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Stock Price Prediction Technical Valuation Financials Earnings Should I Buy News & Events

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

TECH News

Investor Rights Law Firm Investigates Multiple Companies

1d agoGlobenewswire

Multiple Companies Under Investigation for Merger Deal Fairness

1d agoGlobenewswire

Investor Rights Law Firm Investigates Multiple Companies

5d agoPRnewswire

Investigation into Bio-Techne's Merck Transaction

5d agoGlobenewswire

Market Capitalization Comparison of Bio-Techne and Charles River Laboratories

6d agoNASDAQ.COM

Investor Rights Law Firm Investigates Multiple Companies

Jun 30 2026Globenewswire

Investigation Alerts for Multiple Company Mergers

Jun 30 2026Globenewswire

Nike Shares Plummet, Underperforming in Dow Industrials

Jun 30 2026CNBC

TECH Events

Evercore ISI Downgrades Bio-Techne to In Line with $73 Price Target

Evercore ISI downgraded Bio-Techne (TECH) to In Line from Outperform with a $73 price target after the company agreed to be acquired by Merck KGaA (MKGAY) for $73 per share in cash.

TECH Monitor News

Merck KGaA to Acquire Bio-Techne for $11.3 Billion

Bio-Techne Corp rises despite market weakness

Bio-Techne and Refeyn Launch Innovative Antibody Characterization Workflow

Bio-Techne Reports Mixed Q3 Results Amid Dividend Announcement

Bio-Techne Corp hits 5-day low amid market decline

Bio-Techne Corp rises as it crosses above 5-day SMA

Bio-Techne Reports Strong Q2 Results with Double-Digit Growth

Bio-Techne Corp reaches 20-day high amid market gains

TECH Earnings Analysis

Bio-Techne Earnings Q1 FY2026: Mixed Results Analyzed- Intellectia AI™

Bio-Techne Q4 2025 Earnings Rise on Strong Segment Results- Intellectia AI™

People Also Watch